Vaccination coverage against hepatitis A and B viruses, Streptococcus pneumoniae, seasonal flu, and A(H1N1)2009 pandemic influenza in HIV-infected patients.

作者: Florent Valour , Laurent Cotte , Nicolas Voirin , Matthieu Godinot , Florence Ader

DOI: 10.1016/J.VACCINE.2014.06.015

关键词:

摘要: Background Several vaccines are recommended in HIV-infected patients due to an increased risk of vaccine-preventable infections, severe forms the disease, or shared transmission routes. Few data available regarding vaccination coverage and its determinants this population. Methods A cross-sectional study was performed included a hospital-based cohort 2011. Vaccination against hepatitis A virus (HAV), B (HBV), seasonal A(H1N1)2009 pandemic influenza, invasive pneumococcal diseases (IPD) were recorded. Factors associated with assessed by multivariate logistic regression. Results 2467 (median age: 47 years; male gender 71.5%; men having sex (MSM): 43.9%; CDC stage C: 24.3%; HBV and/or C co-infection: 14.4%). Median duration HIV infection 10 years 93.1% received combination antiretroviral therapy. At baseline, median CD4 count 527 cells/mm3 viral load 200/mm3 HIV-RNA <50 copies/mL (IPD, influenza), longer follow-up experienced physician (HBV, IPD). Conclusions Vaccination remained insufficient for all infections investigated study. Determinants largely not evidence-based, efforts should be focused on improving physicians’ knowledge about guidelines.

参考文章(36)
S. Ida, N. Tachikawa, A. Nakajima, M. Daikoku, M. Yano, Y. Kikuchi, A. Yasuoka, S. Kimura, S. Oka, Influence of human immunodeficiency virus type 1 infection on acute hepatitis A virus infection. Clinical Infectious Diseases. ,vol. 34, pp. 379- 385 ,(2002) , 10.1086/338152
F. Denis, R. Cohen, A. Martinot, J.-P. Stahl, T. Lery, M. Le Danvic, J. Gaudelus, Evolution of hepatitis B vaccine coverage rates in France between 2008 and 2011 Medecine Et Maladies Infectieuses. ,vol. 43, pp. 272- 278 ,(2013) , 10.1016/J.MEDMAL.2013.06.016
Tandakha Ndiaye Dieye, Papa Salif Sow, Thierry Simonart, Aı̈ssatou Guèye-Ndiaye, Stephen J Popper, Marie-Luce Delforge, Alioune Dieye, Abdoulaye Dieng Sarr, Alain Crusiaux, Jean-Paul Van Vooren, Michel Devleeschouwer, Phyllis Kanki, Souleymane Mboup, Lamine Diakhate, Claire-Michèle Farber, Immunologic and virologic response after tetanus toxoid booster among HIV-1- and HIV-2-infected Senegalese individuals. Vaccine. ,vol. 20, pp. 905- 913 ,(2001) , 10.1016/S0264-410X(01)00383-8
L. Cotte, N. Voirin, C. Richard, C. Brochier, I. Schlienger, P. Lack, B. Lina, P. Vanhems, F. Zoulim, Factors associated with pandemic influenza A/H1N1 vaccine coverage in a French cohort of HIV-infected patients Vaccine. ,vol. 29, pp. 5638- 5644 ,(2011) , 10.1016/J.VACCINE.2011.06.013
Marcus D Durham, Kate Buchacz, Carl Armon, Pragna Patel, Kathy Wood, John T Brooks, HOPS Investigators, Rates and correlates of influenza vaccination among HIV-infected adults in the HIV Outpatient Study (HOPS), USA, 1999–2008 Preventive Medicine. ,vol. 53, pp. 89- 94 ,(2011) , 10.1016/J.YPMED.2011.04.015
Frank P Kroon, Jaap T van Dissel, Jan C de Jong, Koos Zwinderman, Ralph van Furth, Antibody response after influenza vaccination in HIV-infected individuals : a consecutive 3-year study Vaccine. ,vol. 18, pp. 3040- 3049 ,(2000) , 10.1016/S0264-410X(00)00079-7
Angie Bone, Jean-Paul Guthmann, Javier Nicolau, Daniel Lévy-Bruhl, Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign. Vaccine. ,vol. 28, pp. 8157- 8161 ,(2010) , 10.1016/J.VACCINE.2010.09.096